BrainChip Faces Boardroom Revolt as Sequora Licensing Push Leaves Revenue Question Unanswered

BrainChip is fighting a two-front battle. On one side, two former directors are pushing for a shake-up of the company's leadership; on the other, the Australian chip specialist is still hunting for the first hard evidence that its newest processor technology can actually generate revenue.

The activist campaign, led by the ex-directors, seeks a shareholder meeting under Section 249D of Australian corporate law to force changes to the board. BrainChip has pushed back firmly, urging investors to reject the former executives' efforts. The standoff lays bare growing friction over strategy and governance at the technology firm.

Sequora Goes Commercial, but the Money Stays Theoretical

The governance fight is unfolding against the backdrop of a product milestone. On October 14, BrainChip announced the commercial availability of Sequora, a licensable processor IP core that extends the company's existing Akida platform. The architecture is built to run generative AI and large language models directly on battery-powered edge devices, handling generative workloads and supporting models of up to three billion parameters — a design aimed at applications where heavy computation must happen without a constant link to data centers.

What the company has not disclosed is who will pay for it. BrainChip has named no licensees and published no pricing model. While talks with potential customers are underway, management has conceded it cannot reliably forecast future licensing income, market acceptance, or the overall financial impact of the new IP. For investors, commercialization remains the central unknown.

A Share Price Still Searching for a Floor

The combination of an early-stage business and a leadership conflict has weighed on the stock. BrainChip closed yesterday at EUR 0.0747, bringing its loss since the start of the year to 30 percent. With a market capitalization of EUR 193.02 million, the valuation now hinges largely on whether initial customer conversations turn into binding licensing agreements with established chipmakers or device manufacturers.

Beyond the technology itself, BrainChip is working to raise its profile — it plans to attend the Semiconductor Australia 2026 industry conference. On the home exchange, two notices were filed under ASX Listing Rule 3.17.1, though no detailed documents were publicly highlighted. Until contractually fixed revenue from the Sequora launch materializes, the operational turnaround remains speculative — and with the dispute over convening a shareholder meeting still unresolved, uncertainty about the company's direction looks set to persist.